Sabrina Germoni
Rome, 00144, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Retraction Note: Exemestane blocks mesothelioma growth through downregulation of cAMP, pCREB and CD44 implicating new treatment option in patients affected by this disease.
Journal: Molecular cancer
Published: December 09, 2022
Reduction of estradiol in human malignant pleural mesothelioma tissues may prevent tumour growth, as implied by in in-vivo and in-vitro models.
Journal: Oncotarget
Published: February 23, 2016
Che-1 modulates the decision between cell cycle arrest and apoptosis by its binding to p53.
Journal: Cell death & disease
Published: September 23, 2014
Exemestane blocks mesothelioma growth through downregulation of cAMP, pCREB and CD44 implicating new treatment option in patients affected by this disease.
Journal: Molecular cancer
Published: December 02, 2013
Inhibition of p85, the non-catalytic subunit of phosphatidylinositol 3-kinase, exerts potent antitumor activity in human breast cancer cells.
Journal: Cell death & disease
Published: December 11, 2012
miR-204 targets Bcl-2 expression and enhances responsiveness of gastric cancer.
Journal: Cell death & disease
Published: November 16, 2012
miR-10b*, a master inhibitor of the cell cycle, is down-regulated in human breast tumours.
Journal: EMBO molecular medicine
Published: November 06, 2012
Molecular imaging of nuclear factor-Y transcriptional activity maps proliferation sites in live animals.
Journal: Molecular biology of the cell
Published: March 02, 2012
SASP mediates chemoresistance and tumor-initiating-activity of mesothelioma cells.
Journal: Oncogene
Published: October 25, 2011
Showing 1-9 of 9
Last Updated: 09/26/2026